Bayer

2013 Should Be Interesting for Multiple Sclerosis Drugs
The Motley Fool
Mon, 12/31/12 - 04:36 pm
multiple sclerosis
drugs
Teva Pharmaceuticals
Pfizer
Merck
Biogen
Bayer
Novartis
It's Hard to Make Money When FDA Approvals Are Priced In
Motley Fool
Mon, 12/17/12 - 09:31 am
FDA
drug approvals
Ariad Pharmaceuticals
Novartis
Dendreon
Medivation
Bayer
ONYX Pharmaceuticals
Otsuka
Bristol-Myers Squibb
The Next Wave of Diabetes Dominance
Motley Fool
Wed, 12/12/12 - 08:11 am
diabetes
Bayer
Sanofi
Novo Nordisk
Abbott Labs
Bristol-Myers Squibb
Sanofi's last on the list to buy Bayer's glucose devices
Mass Device
Mon, 12/10/12 - 12:08 pm
Sanofi
M&A
Bayer
diabetes
Bayer diabetes unit sale unlikely - sources
Reuters
Fri, 12/7/12 - 10:37 am
Bayer
diabetes
M&A
Sanofi
Pharmaceutical company Bayer acquires nutritional supplement company Schiff
examiner.com
Sat, 11/24/12 - 12:21 pm
Bayer
Schiff
M&A
Bayer: 5 key drugs to have combined peak sales of 5.5 bln eur
Reuters
Wed, 11/14/12 - 10:16 am
Bayer
Bayer to test Xarelto in heart attack prevention
Reuters
Tue, 11/13/12 - 11:48 am
Bayer
Xarelto
heart attacks
Bayer HealthCare joins with Medsintez to boost presence in Russia
The Pharma Letter
Fri, 11/2/12 - 10:06 am
Russia
Medsintez
Bayer
Bayer to buy U.S. vitamin maker Schiff for $1.2 bln
Reuters
Thu, 11/1/12 - 11:18 am
Bayer
M&A
Schiff
vitamins
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Lpath
Pfizer
iSONEP
Asonept
macular degeneration
multiple sclerosis
MS
Regeneron
Roche
Bayer
Sanofi
Valeant Pharmaceuticals
GSK
Shire CEO to Retire in 2013; Bayer’s Ornskov Gets Top Job
Bloomberg
Thu, 10/25/12 - 11:50 am
Shire
Bayer
Pharma CEOs
Angus Russell
Flemming Ornskov
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Mon, 10/22/12 - 12:09 pm
Bayer
PAH
Actelion
Gilead
Riociguat
Tracleer
Bayer wins EU endorsement for Xarelto in lung embolism
Reuters
Fri, 10/19/12 - 11:11 am
Europe
Bayer
Xarelto
pulmonary embolism
Merck gets rights to HCMV drug from Bayer spin-off AiCuris
Pharma Times, UK
Mon, 10/15/12 - 11:40 am
Merck
Bayer
AiCuris
HCMV
letermovir
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Bayer’s Nexavar May Have Prolonged Life in Some Lung Patients
Bloomberg
Sat, 09/29/12 - 11:57 am
Nexavar
Bayer
lung cancer
Bayer, Onyx Win U.S. Approval for Colorectal Cancer Treatment
Bloomberg
Thu, 09/27/12 - 11:26 am
colorectal cancer
Bayer
ONYX Pharmaceuticals
FDA
regorafenib
Bayer CEO decries pressure to lower drug prices
Reuters
Thu, 09/20/12 - 11:55 am
Bayer
Pharma CEOs
drug pricing
Marijn Dekkers
Bayer seeks EU approval for birth control patch
Reuters
Thu, 09/20/12 - 11:19 am
Bayer
Europe
contraceptive patch
JNJ
Ortho Evra

Pages